Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B Lopez-Montesinos
Fri0555 Influence of Anti-Tumornecrosis Factor (Tnf) Drug Immunogenicity on the Treatment Effectiveness in Juvenile Idiopathic Arthritis (Jia) Using Serum Calprotectin as a Disease Activity Marker. Multicenter Study. Itaca Study
Related publications
Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Kre-Celazine®As a Viable Treatment for Juvenile Rheumatoid Arthritis/Juvenile Idiopathic Arthritis — A Pilot Study
Journal of Medicinal Food
Medicine
Nutrition
Dietetics
Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis
Journal of Pediatric Gastroenterology and Nutrition
Child Health
Pediatrics
Perinatology
Gastroenterology
German Evidence- And Consensus-Based Guidelines 2011 for the Treatment of Juvenile Idiopathic Arthritis (JIA)
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Remission, Minimal Disease Activity, and Acceptable Symptom State in Juvenile Idiopathic Arthritis: Defining Criteria Based on the Juvenile Arthritis Disease Activity Score
Arthritis & Rheumatism
Long-Term Outcomes in Juvenile Idiopathic Arthritis: 18 Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis (JIA) Cohort
Arthritis Care and Research
Rheumatology
14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): Can Extension Be Predicted?
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
AB0222 the Serum Anti-Citrullinated Protein/Peptide Antibodies in Children With Juvenile Idiopathic Arthritis
Dermatomyositis Induced by Anti–Tumor Necrosis Factor in a Patient With Juvenile Idiopathic Arthritis
JAMA Dermatology
Dermatology
Medicine
